Tech Company Financing Transactions
SixPeaks Bio Funding Round
SixPeaks Bio, based in Basel, raised $110 million from Versant Ventures and AstraZeneca.
Transaction Overview
Company Name
Announced On
5/22/2024
Transaction Type
Venture Equity
Amount
$110,000,000
Round
Series A
Investors
Versant Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Versant Ridgeline Discovery Engine, Basel Technology Park
Basel, 4057
Switzerland
Basel, 4057
Switzerland
Phone
Undisclosed
Email Address
Not Recorded
Overview
SixPeaks is developing a pipeline of best- and first-in-class medicines for healthy weight loss. The company emerged from Versant Ventures' Ridgeline Discovery Engine in the Basel Technology Park.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philip Larsen
Browse more venture capital transactions:
Prev: 5/22/2024: Vaxess Technologies venture capital transaction
Next: 5/22/2024: PolarityTE venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs